Neo-antigen specific cancer vaccines for acute lymphoblastic leukemia—challenges, opportunities, and future directions
Abstract Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, with standard treatment consisting of intensive chemotherapy and corticosteroids. While curative in most cases, this regimen leads to significant toxicity and long-term sequelae. Recent advancements in cancer immuno...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer
2025-06-01
|
| Serija: | Cancer Immunology, Immunotherapy |
| Teme: | |
| Online dostop: | https://doi.org/10.1007/s00262-025-04107-y |
| Oznake: |
Brez oznak, prvi označite!
|